Clinical Trial Update: A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

View source ↗

Summary

Clinical trial update reports the completion of a study of Vedolizumab (Kynteles) in adults with moderate-to-severe ulcerative colitis, Crohn's disease, and chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Pouchitis
• Ulcerative Colitis

Drugs mentioned

• Kynteles (Vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Inflammatory Bowel Diseases, Colitis, Ulcerative | Status: COMPLETED